<PAGE> 1
OMB APPROVAL
-------------------------
OMB Number: 3235-0145
Expires: October 31,1997
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
US Servis, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
902941 10 3
----------------------------
(CUSIP Number)
Frederick R. Blume (312) 427-1227
American Healthcase Fund, 122 S. Michigan Ave., Ste. 1320, Chicago, IL
60603
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 30, 1996
--------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
SCHEDULE 13D
CUSIP NO. 902941 10 3 PAGE 2 OF 12 PAGES
---------------- --- ------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
American Healthcare Fund, L.P., IRS No. 36-3474859
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ---------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON WITH 470,811
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
470,811
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
470,811
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / /
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.33%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 OF 7
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 902941 10 3 PAGE 3 OF 12 PAGES
---------------- --- ------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Capital Health Management, L.P., IRS No. 36-3377093
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ---------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING Beneficial ownership is disclaimed
PERSON WITH 470,811 pursuant to Rule 13d-4.
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / /
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.33%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 OF 7
<PAGE> 4
SCHEDULE 13D
CUSIP NO. 902941 10 3 PAGE 4 OF 12 PAGES
---------------- --- ------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Frederick R. Blume
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ---------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING Beneficial ownership is disclaimed
PERSON WITH 470,811 pursuant to Rule 13d-4.
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / /
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.33%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 OF 7
<PAGE> 5
SCHEDULE 13D
CUSIP NO. 902941 10 3 PAGE 5 OF 12 PAGES
---------------- --- ------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kinney L. Johnson
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ---------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING Beneficial ownership is disclaimed
PERSON WITH 470,811 pursuant to Rule 13d-4.
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / /
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.33%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 OF 7
<PAGE> 6
SCHEDULE 13D
CUSIP NO. 902941 10 3 PAGE 6 OF 12 PAGES
---------------- --- ------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Daniel J. Mitchell
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ---------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING Beneficial ownership is disclaimed
PERSON WITH 470,811 pursuant to Rule 13d-4.
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Beneficial ownership is disclaimed
470,811 pursuant to Rule 13d-4.
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / /
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.33%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2 OF 7
<PAGE> 7
CUSIP NO. 902941 10 3 PAGE 7 OF 12 PAGES
------------- --- ----
SCHEDULE 13D
ITEM 1: Security and Issuer
Class of Securities: Common Stock
Issuer: US Servis, Inc. (fka MICRO Healthsystems, Inc.) ("Issuer")
Principal Address: 220 Davidson Avenue
Somerset, New Jersey 08873
ITEM 2: Identity and Background
1. (a) Reporting Person: American Healthcare Fund, L.P. ("Fund")
(b) Place of Organization: Illinois
(c) Principal Business: Venture capital fund
(d) Principal Business Address: 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(e) Principal Office: Same as above
(f) Criminal Convictions: None
(g) Civil Adjudication of
Violation of Securities Laws: None
2. (a) Reporting Person: Capital Health Management L.P.
("Management")
(b) Place of Organization: Illinois
(c) Principal Business: General partner of fund
(d) Principal Business Address: 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(e) Principal Office: Same as above
(f) Criminal Convictions: None
<PAGE> 8
CUSIP NO. 902941 10 3 PAGE 8 OF 12 PAGES
------------- --- ----
(g) Civil Adjudication of
Violation of Securities Laws: None
3. (a) Reporting Person: Frederick R. Blume ("Blume")
(b) Business Address: 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(c) Principal Employment,
Name of Employer: Mr. Blume is a general partner of
Management
Address of Employer 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(d) Criminal Convictions: None
(e) Civil Adjudication of
Violation of Securities Laws: None
(f) Citizenship: United States
4. (a) Reporting Person: Kinney L. Johnson ("Johnson")
(b) Business Address: 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(c) Principal Employment,
Name of Employer: Mr. Johnson is a general partner of
Management
Address of Employer 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(d) Criminal Convictions: None
(e) Civil Adjudication of
Violation of Securities Laws: None
(f) Citizenship: United States
<PAGE> 9
CUSIP NO. 902941 10 3 PAGE 9 OF 12 PAGES
------------- --- ----
5. (a) Reporting Person: Daniel J. Mitchell ("Mitchell")
(b) Business Address: 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(c) Principal Employment,
Name of Employer: Mr. Mitchell is a general partner of
Management
Address of Employer 122 S. Michigan Avenue
Suite 1320
Chicago, Illinois 60603
(d) Criminal Convictions: None
(e) Civil Adjudication of
Violation of Securities Laws: None
(f) Citizenship: United States
THE FOLLOWING ITEMS 3 THROUGH 6 ARE PROVIDED AS TO ALL REPORTING PERSONS SET
FORTH ABOVE.
ITEM 3. Source and Amount of Funds or Other Considerations
At various times beginning in May 1990, Fund purchased capital stock
and convertible notes of Applied Computer Technology for Patient Care, Inc., a
Delaware corporation ("ACT/PC"), for an aggregate purchase price of $1,706,976.
The source of the purchase price for such stock and convertible notes was
venture capital funds held by Fund. On August 31, 1993, Issuer purchased and
assumed (the "Acquisition") substantially all of the assets and liabilities of
ACT/PC in consideration of Issuer's issuance of shares of its Common Stock to
ACT/PC. Pursuant to ACT/PC's subsequent dissolution proceeding, Fund acquired
beneficial ownership of 266,067 shares of Issuer's Common Stock, which shares
represented Fund's pro rata allocation of the liquidated assets of ACT/PC to
which Fund was entitled as s stockholder of ACT/PC.
Pursuant to the Acquisition, Issuer assumed certain convertible notes
of ACT/PC held by Fund in the aggregate principal amount of $540,000. Fund
subsequently purchased 79,744 shares of the Issuer's Common Stock for $598,093
by cancellation of the indebtedness owed to it and represented by such
convertible notes.
<PAGE> 10
CUSIP NO. 902941 10 3 PAGE 10 OF 12 PAGES
------------- ---- ----
On September 30, 1996, Fund purchased for cash 125,000 shares of Series
B Convertible Preferred Stock of the Issuer for an aggregate purchase price of
$500,000. The source of funds for the purchase was the Fund's venture capital
fund.
ITEM 4: Purpose of Transaction
Fund purchased the stock and convertible notes of ACT/PC as in
investment opportunity. Fund subsequently acquired beneficial ownership of
shares of Common Stock and Convertible Preferred Stock of Issuer as an
investment opportunity. Frederick R. Blume, one of the general partners of the
general partner of Fund, is a member of the board of directors of Issuer.
ITEM 5: Interest in Securities
1. Reporting Entities: Fund Management
Beneficial Ownership: 470,811 470,811
Percentage Ownership: 7.33% 7.33%
Sole Voting Power: None None
Shared Dispositive Power: 470,811 470,811
Sole Dispositive Power: None None
Shared Dispositive Power: 470,811 470,811
Ownership below 5%: Not applicable
2. Reporting Individuals: Blume Johnson Mitchell
Beneficial Ownership: 470,811 470,811 470,811
Percentage Ownership: 7.33% 7.33% 7.33%
Sole Voting Power: None None None
Shared Voting Power: 470,811 470,811 470,811
Shared Dispositive Power: None None None
Shared Dispositive Power: 470,811 470,811 470,811
Ownership below 5%: Not applicable
<PAGE> 11
CUSIP NO. 902941 10 3 PAGE 11 OF 12 PAGES
------------- --- ---
Pursuant to the Acquisition, Issuer assumed certain convertible notes of
ACT/PC held by Fund in the aggregate principal amount of $540,000. On August
31, 1993, Fund purchased 79,744 shares of the Issuer's Common Stock for $7.50
per share by cancellation of the indebtedness (including principal and
interest) owed to it and represented by such convertible notes. Such 79,744
shares of Issuer's Common Stock represent 1.46% of Issuer's outstanding shares
of Common Stock.
On October 7, 1993, pursuant to ACT/PC's dissolution proceedings, Fund
acquired beneficial ownership of 266,067 shares (the "Liquidation Shares") of
Issuer's Common Stock, which shares represented Fund's pro rata allocation of
the liquidated assets of ACT/PC to which Fund was entitled as a stockholder of
ACT/PC. Based upon an aggregate of $1,166,976 paid by Fund for the purchase
of ACT/PC capital stock at various times from May 1990 to August 1993, Fund
acquired the Liquidated Shares for an indirect price per share of $4.386.
On September 30, 1996, Fund purchased for cash 125,000 shares of
Series B Convertible Preferred Stock of the Issuer for an aggregate purchase
price of $500,000. The source of funds for the purchase was the Fund's venture
capital fund.
Each of Management, Blume, Johnson and Mitchell expressly declares that
the filing of this Schedule 13D shall not be construed as an admission that such
entity or person is, for purposes of Section 13(d) or Section 13(g), the
beneficial owner of the shares of Common Stock of Issuer identified in this
Schedule 13D.
Under certain circumstances set forth in Fund's limited partnership
agreement, Management (as general partner) and the limited partners of Fund
have the right to receive dividends from, or the proceeds from the sale of, the
Common Stock of Issuer.
ITEM 6: Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer
In connection with the acquisition of Series B Convertible Preferred
Stock of the Issuer, the Issuer granted certain registration rights to the Fund
with respect to the shares of Common Stock of the Issuer that may be acquired
by the Fund upon conversion of the Series B Convertible Preferred Stock.
In connection with the acquisition of Series B Convertible Preferred
Stock, the Issuer granted to the Fund certain preemptive rights to subscribe
for a pro rata portion of any additional issuances of securities by the Issuer.
ITEM 7: Exhibits
Exhibit A: Joint Filing Statement(1)
Exhibit B: Letter of Issuer to Blume, dated August 24, 1993.(1)
(1) Incorporated by reference from Schedule 13D filed October 18, 1993.
<PAGE> 12
CUSIP NO. 902941 10 3 PAGE 12 OF 12 PAGES
------------- ---- ----
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 13, 1997
AMERICAN HEALTCHARE FUND, L.P.
By its general partner
Capital Health Management, L.P.
/s/ Frederick R. Blume
- -----------------------------
By: Frederick R. Blume
Title: General Partner
CAPITAL HEALTH MANAGEMENT, L.P.
/s/ Frederick R. Blume
- ------------------------------
By: Frederick R. Blume
Title: General Partner
/s/ Frederick R. Blume
- ------------------------------
Frederick R. Blume
/s/ Kinney L. Johnson
- ------------------------------
Kinney L. Johnson
/s/ Daniel J. Mitchell
- ------------------------------
Daniel J. Mitchell
